Researchers compare drugs for treating severe hypertension in pregnancy

pregnancy
Credit: CC0 Public Domain

A recent meta-analysis of published studies has compared the efficacy and safety of antihypertensive drugs during pregnancy.

In the British Journal of Clinical Pharmacology, investigators reported similar efficacy between nifedipine, hydralazine, and labetalol, and negligible differences were observed in their safety profile. The available evidence was inadequate for other drugs. Moderate quality of evidence was observed for direct comparison estimates between labetalol and hydralazine, but was either low or very low for other comparisons.

Labetalol, hydralazine, and nifedipine are likely comparable for treating acute-onset, severe hypertension in pregnancy, noted the authors, Dr. Kannan Sridharan and Prof. Reginald Sequeira, of Arabian Gulf University, in Bahrain.


Explore further

Rise in use of antihypertensives in delivery with preeclampsia

More information: Kannan Sridharan et al, Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials, British Journal of Clinical Pharmacology (2018). DOI: 10.1111/bcp.13649
Provided by Wiley
Citation: Researchers compare drugs for treating severe hypertension in pregnancy (2018, July 5) retrieved 21 October 2019 from https://medicalxpress.com/news/2018-07-drugs-severe-hypertension-pregnancy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more